Outlook Therapeutics: New CFO Kevin Lundquist Discusses Company's Future

Outlook Therapeutics, Inc. is highlighting the significance of new Chief Financial Officer Kevin Lundquist's appointment, with Lundquist discussing his decision to join the company and its future path following the FDA approval of LYTENAVA™.